Levi & korsinsky reminds shareholders of a lead plaintiff deadline of march 4, 2025 in revance lawsuit - rvnc

New york, ny / accesswire / january 13, 2025 / if you suffered a loss on your revance therapeutics, inc. (nasdaq:rvnc) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/revance-therapeutics-inc-lawsuit-submission-form?prid=122569&wire=1 or contact joseph e. levi, esq.
RVNC Ratings Summary
RVNC Quant Ranking